Can a software only mobile solution outperform a pharmaceutical drug in clinical trials? Is it possible to create an app only available via a doctor\u2019s prescription? The answer to both questions is a responding YES!<\/p>\n
In this webinar, Dan walked through several medical product case studies he has consulted on. The first is the WellDoc BlueStar solution for type 2 diabetes patients. BlueStar was the first instance of Digital Medicine invented. BlueStar received both an FDA class 2 certification and a prescription drug code for insurance reimbursement. Legally speaking this 100% software only solution is a medication. In clinical trials it has proven to reduce high-risk type 2 patients A1C levels by more than 1.8 points, outperforming many commonly prescribed medications. The second case study is Bigfoot Biomedical\u2019s artificial pancreas for type 1 diabetics. It has completed its first clinical trial rounds but is not yet in the market. This solution uses an amazing combination of AI, big data and IoT embedded in the human body to automate insulin delivery 24\/7. The primary UX resides on the patients\u2019 phone. Interfaces for doctors and insurance companies will complete the end to end system experience including an innovative direct to patients supply chain. In addition to these amazing case studies this webinar described the similarities between digital medicine design and Enterprise UX. You will be surprised to see how much they have in common as well as what else you need to know to enter this cutting-edge UX domain.<\/p>\n","protected":false},"excerpt":{"rendered":"
Can a software<\/strong> only mobile solution outperform a pharmaceutical drug in clinical trials? Is it possible to create an app only available via a doctor’s prescription? The answer to both…<\/span><\/p>\n","protected":false},"author":150241,"featured_media":146,"template":"","session-theme":[],"session-type":[843],"rm-permissions":[],"event-type":[868],"acf":[],"_links":{"self":[{"href":"https:\/\/rosenfeldmedia.com\/wp-json\/wp\/v2\/sessions\/246491"}],"collection":[{"href":"https:\/\/rosenfeldmedia.com\/wp-json\/wp\/v2\/sessions"}],"about":[{"href":"https:\/\/rosenfeldmedia.com\/wp-json\/wp\/v2\/types\/sessions"}],"author":[{"embeddable":true,"href":"https:\/\/rosenfeldmedia.com\/wp-json\/wp\/v2\/users\/150241"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rosenfeldmedia.com\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/rosenfeldmedia.com\/wp-json\/wp\/v2\/media?parent=246491"}],"wp:term":[{"taxonomy":"session-theme","embeddable":true,"href":"https:\/\/rosenfeldmedia.com\/wp-json\/wp\/v2\/session-theme?post=246491"},{"taxonomy":"session-type","embeddable":true,"href":"https:\/\/rosenfeldmedia.com\/wp-json\/wp\/v2\/session-type?post=246491"},{"taxonomy":"rm-permissions","embeddable":true,"href":"https:\/\/rosenfeldmedia.com\/wp-json\/wp\/v2\/rm-permissions?post=246491"},{"taxonomy":"event-type","embeddable":true,"href":"https:\/\/rosenfeldmedia.com\/wp-json\/wp\/v2\/event-type?post=246491"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}